Xue, Rudelyn .

HRN: 24-85-87  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2024
CEFUROXIME 500MG (TAB)
04/30/2024
05/07/2024
PO
500mg
BID X 7 Days
S/P NSVD With RMLE And Repair
Waiting Final Action 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes